Results
10
10 companies
Celon Pharma
Market Cap: zł1.4b
An integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations.
CLN
zł26.15
7D
-4.7%
1Y
70.0%
Selvita
Market Cap: zł690.2m
Operates as a contract research organization worldwide.
SLV
zł37.60
7D
-13.0%
1Y
-45.5%
Ryvu Therapeutics
Market Cap: zł563.0m
A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.
RVU
zł24.35
7D
1.9%
1Y
-55.4%
BIOTON
Market Cap: zł316.0m
A biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally.
BIO
zł3.68
7D
2.6%
1Y
3.2%
Mabion
Market Cap: zł153.5m
A biotechnology company, engages in the development of various biotech drugs based on monoclonal antibody technology in Poland.
MAB
zł9.50
7D
-6.5%
1Y
-43.1%
Molecure
Market Cap: zł151.2m
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of neoplastic and inflammatory diseases in Poland.
MOC
zł8.98
7D
-2.4%
1Y
-47.2%
Biogened
Market Cap: zł68.8m
Develops, produces, and distributes pharmaceutical products in Poland.
BGD
zł28.00
7D
3.7%
1Y
8.5%
Read-Gene
Market Cap: zł50.6m
Engages in the detection, prevention, and treatment of various types of cancer.
RDG
zł4.29
7D
-1.2%
1Y
-18.1%
Labocanna
Market Cap: zł7.8m
Engages in the cultivation, production, and distribution of hemp product.
LCN
zł0.37
7D
2.8%
1Y
-18.5%
Stem Cells Spin
Market Cap: zł7.0m
Operates as a biotechnology company in Poland.
SCS
zł0.17
7D
-3.4%
1Y
-66.1%